We all have a lot to learn ! I also took a hit on CXS - took a gamble on the FDA 2nd meeting before seeing the full transcript of the first meeting and relied on the press releases and company releases.
Then when seeing the FDA release - I extended my research and understanding and exited.
The problem with being in this sort of share only on fundamentals is that the technical analysis (TA) guys have a big advantage - so try and use a bit of both. Even if it is the "Shoot from the Hip" technical analysis that we all do by looking at share price movements and volume = the price, volume and time analysis that the TA guys process.
Anyone out there for TA happy to show their decisions and movements over the last month ?
CXS Price at posting:
41.0¢ Sentiment: Sell Disclosure: Not Held
